I agree that this site is using cookies. You can find further informations here.
X
Rossing, P.
716  results:
Search for persons X
?
1

Efficacy and safety of finerenone in patients with chronic ..:

Mentz, R ; Anker, S ; Pitt, B...
European Heart Journal.  44 (2023)  Supplement_2 - p. , 2023
Link: https://doi.org/10.1093/..
 
?
2

WCN23-0618 CARDIORENAL OUTCOMES WITH FINERENONE IN ASIAN PA..:

Koya, D. ; Ruilope, L.M. ; Rossing, P....
Kidney International Reports.  8 (2023)  3 - p. S196-S197 , 2023
Link: https://doi.org/10.1016/..
 
?
3

Myocardial performance index improves prediction of major a..:

Bahrami, H ; Jorgensen, P G ; Hove, J D...
European Heart Journal.  44 (2023)  Supplement_2 - p. , 2023
Link: https://doi.org/10.1093/..
 
?
4

Effect of finerenone in patients with chronic kidney diseas..:

Singh, A ; Anker, S D ; Filippatos, G...
European Heart Journal.  44 (2023)  Supplement_2 - p. , 2023
Link: https://doi.org/10.1093/..
 
?
5

IDF2022-1255 Efficacy and safety of finerenone by age and s..:

Bansal, S. ; Anker, S. ; Bakris, G....
Diabetes Research and Clinical Practice.  197 (2023)  - p. 110545 , 2023
Link: https://doi.org/10.1016/..
 
?
6

Effects of dapagliflozin on cardiovascular and kidney event..:

Moura, F ; Wiviott, S ; Chertow, G...
European Heart Journal.  43 (2022)  Supplement_2 - p. , 2022
Link: https://doi.org/10.1093/..
 
?
7

POS-255 EFFECT OF DAPAGLIFLOZIN ON BLOOD PRESSURE IN PATIEN..:

Provenzano, M. ; Toto, R.D. ; Vart, P....
Kidney International Reports.  7 (2022)  2 - p. S112 , 2022
Link: https://doi.org/10.1016/..
 
?
8

POS-202 DAPAGLIFLOZIN IN PATIENTS WITH CHRONIC KIDNEY DISEA..:

Provenzano, M. ; Jongs, N. ; Stefánsson, B.V....
Kidney International Reports.  7 (2022)  2 - p. S86-S87 , 2022
Link: https://doi.org/10.1016/..
 
?
9

In patients with type 2 diabetes chronic kidney disease is ..:

Agarwal, R ; Pitt, B ; Rossing, P...
European Heart Journal.  43 (2022)  Supplement_2 - p. , 2022
Link: https://doi.org/10.1093/..
 
?
10

Baseline cardiovascular risk in subjects with type 2 diabet..:

Mahaffey, K W ; Baeres, F M M ; Bakris, G...
European Heart Journal.  43 (2022)  Supplement_2 - p. , 2022
Link: https://doi.org/10.1093/..
 
?
11

POS-350 FINERENONE IN MILD TO SEVERE CHRONIC KIDNEY DISEASE..:

Rossing, P. ; Agarwal, R. ; Anker, S.D....
Kidney International Reports.  7 (2022)  2 - p. S157-S158 , 2022
Link: https://doi.org/10.1016/..
 
?
12

The effects of dapagliflozin on kidney and cardiovascular o..:

Heerspink, J L ; Wheeler, D C ; Vart, P...
European Heart Journal.  42 (2021)  Supplement_1 - p. , 2021
Link: https://doi.org/10.1093/..
 
?
13

The low-expression variant of FABP4 is associated with card..:

Dahlström, E.H. ; Saksi, J. ; Forsblom, C....
Atherosclerosis.  331 (2021)  - p. e223-e224 , 2021
Link: https://doi.org/10.1016/..
 
?
14

POS-832 DAPAGLIFLOZIN IN IgA NEPHROPATHY: FINDINGS FROM THE..:

Lambers Heerspink, H. ; Toto, R.D. ; Jongs, N....
Kidney International Reports.  6 (2021)  4 - p. S362 , 2021
Link: https://doi.org/10.1016/..
 
?
15

POS-831 THE EFFECT OF DAPAGLIFLOZIN IN PATIENTS WITH eGFR <..:

Chertow, G.M. ; Vart, P. ; Jongs, N....
Kidney International Reports.  6 (2021)  4 - p. S361-S362 , 2021
Link: https://doi.org/10.1016/..
 
1-15